Abstract:Abstract Reactive infectious mucocutaneous eruption (RIME) is a reactive inflammatory mucositis most commonly but not exclusively associated with Mycoplasma pneumoniae. It presents with a mucosal- predominant eruption with sparse to no skin involvement. We describe four recent cases in children between 6 and 13 years of age. All four children presented with increasing lip discomfort with subsequent lip swelling, sloughing and crusting. The intraoral mucosa was affected to varying degrees. All described a prodromal illness with cough and general malaise, and three patients also reported fevers. Skin manifestation varied, with two patients having no cutaneous involvement while two patients had sparse pink macules and negative Nikolsky sign. Investigations included an extended respiratory screen and chest X-ray to check for underlying infection, and M. pneumoniae was detected in two patients. Skin swabs for virology and bacteriology were also taken. Management focused on pain control, nutritional support and good mouth care. The patients required admission to hospital for fluid resuscitation and analgesia. Mouth care was implemented with regular benzydamine hydrochloride spray and Gelclair gel, and white soft paraffin alongside Trimovate cream (oxytetracycline and nystatin) for the lips. Due to ongoing diffuse erosions of the buccal mucosae with haemorrhagic crusting of the lips, one patient required a short course of oral steroids. Reactive infectious mucocutaneous eruption was previously termed Mycoplasma pneumoniae-induced rash and mucositis; however, reports of this entity being caused by other infections including enterovirus, influenza B virus and SARS-Cov-2 has led to a change in terminology (Mahama A, Kojder P, Thibodeaux Q, Ruth J. Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: case report and review of the literature. Pediatr Dermatol 2023; 40: 162–5). Mucosal membranes are significantly more affected than skin in RIME. Skin involvement can be sparse or absent, differentiating it from Stevens–Johnson syndrome/toxic epidermal necrolysis, which presents with rapidly progressive skin necrosis and is often drug induced, and from erythema multiforme, which is characterized by typical target lesions (Tonkin R, Ladha M, Johnson N et al. Reactive infectious mucocutaneous eruption – repeat etanercept after intravenous immunoglobulin: a case report. SAGE Open Med Case Rep 2022; doi: 10.1177/2050313X221117887). Investigations for underlying respiratory infection and treatment with appropriate antibiotic therapy should be implemented. Supportive care in the form of pain relief, and nutritional and fluid support is important. Systemic steroids may be required to truncate the inflammatory response, although there is a lack of prospective data. In conclusion, our aim is to bring awareness to this condition to facilitate its recognition, diagnosis and treatment.

A severe case of reactive infectious mucocutaneous eruption associated with two possible triggers: Coronavirus and group A streptococcus

PA28 Reactive infectious mucocutaneous eruption: a case series of four children

Bilateral Morganella Morganii Keratitis in A Patient with Facial Topical Corticosteroid-Induced Rosacea-Like Dermatitis: A Case Report

Case Report: Clinical and Immunological Features of a Chinese Cohort With Mycoplasma-Induced Rash and Mucositis

Mycoplasma Pneumoniae Induced Rash and Mucositis with Bilateral Otitis Media and Sinusitis

Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario

637: DRESS SYNDROME A CUTANEOUS ADVERSE DRUG REACTION CAUSED BY VANCOMYCIN IN THE CRITICALLY ILL

Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients.

Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia

Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old

Unique Presentation of Mycoplasma pneumoniae-Induced Rash and Mucositis with Salivary Gland Inflammation in a Pediatric Patient: A Case Report

Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report

Strategies for Diagnosing and Treating Disseminated Methicillin-Sensitive Staphylococcus aureus Infections: Insights From a Pustular Eruption

Anti-TNF-α induced mucous membrane pemphigoid-like disease

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

Case report: Drug rash with eosinophilia and systemic symptoms syndrome in a patient with anti-interferon-γ autoantibody-associated immunodeficiency

Erythema Multiforme and COVID-19: What Do We Know?

Coronavirus-disease-2019-associated Stevens-Johnsons syndrome in a 15-year-old boy: a case report and review of the literature

A Rare Presentation of an Adverse Reaction to Minocycline

Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)